Internal Medicine · Acibadem Maslak Hospital, İstanbul Akın Kürklü, MD
✓ Medically verified profileAkın Kürklü, MD
Akın Kürklü, MD is an Internal Medicine specialist at Acibadem Maslak Hospital in İstanbul. He assesses and manages chronic diseases, prediabetes, obesity, metabolic disorders, anaemia, clinical nutrition, geriatric health, and digestive, liver, pancreatic and biliary tract diseases. He consults in Turkish and English, and video consultation is available for international patients.
Accepting international patientsAbout Akın Kürklü, MD
Akın Kürklü, MD is an Internal Medicine specialist at Acibadem Maslak Hospital in İstanbul, where he works within the Internal Medicine unit. He has more than 29 years in medicine. His clinical interests include chronic diseases, prediabetes, obesity, metabolic disorders, anaemia, clinical nutrition and geriatric health, as well as disorders of the digestive system, liver, pancreas and biliary tract.
Dr. Kürklü graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 1997 and completed his Internal Medicine training at Şişli Etfal Training and Research Hospital in 2002. He continued at Şişli Etfal Training and Research Hospital from 2002 to 2006, then worked at Başkent University Research Hospital from 2006 to 2007 and at Medikal Park Hastaneler Grubu from 2008 to 2009. He has been with Acıbadem Healthcare Services since 2009. He is a member of Marmara Diabet Grubu, Türk Diabet Vakfı, the Metabolic Syndrome Association, Türk Diabet Cemiyeti and the European Association for the Study of Diabetes. He has co-authored published papers on topics including markers of diabetic nephropathy, microalbuminuria and hypertension in type 2 diabetes, basal insulin in type 1 diabetes, statin therapy and microalbuminuria, and insulin resistance and serum lipids after myocardial infarction.
Clinical focus
Dr. Kürklü’s practice centers on the assessment and long-term management of chronic and metabolic conditions. This includes prediabetes and other metabolic disorders, obesity, anaemia and clinical nutrition. His membership in diabetes and metabolic health organisations, together with his published work on diabetes, reflects a sustained interest in this field. He also sees patients with general wellness concerns and older adults whose care may involve several coexisting conditions.
A further part of his work involves digestive disorders, including liver diseases, pancreatic diseases and biliary tract diseases. In these areas, an Internal Medicine assessment typically aims to clarify symptoms, review existing findings and previous treatments, and consider which further tests or referrals may be appropriate. Treatment decisions depend on the individual patient’s history, examination and test results.
How Dr. Kürklü works with international patients
Dr. Kürklü consults in Turkish and English, and interpreters can be arranged for other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their situation before travelling.
What Dr. Kürklü treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceGeriatric health
Conditions treated
- Chronic diseases
- Wellness
- Prediabetes
- Obesity
- Anaemia
- Metabolic disorders
- Liver diseases
- Pancreatic diseases
- Biliary tract diseases
- Digestive disorders
Procedures performed
Education, career and memberships
Education & training
Education
- 2002Şişli Etfal Training and Research Hospital Department of Internal Medicine
- 1997İstanbul University Cerrahpaşa Faculty of Medicine
Career
Professional Experience
- 2009Acıbadem Healthcare Services
- 2008–2009Medikal Park Hastaneler Grubu
- 2006–2007Başkent University Research Hospital
- 2002–2006Şişli Etfal Training and Research Hospital
Memberships
Professional Memberships
- Marmara Diabet Grubu
- Türk Diabet Vakfı
- Metabolic Syndrome Association
- Türk Diabet Cemiyeti
- European Association for the Study of Diabetes
Selected publications
Selected Publications
- Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Renal Failure 2006;28(2):125-8 Basturk T, Altuntas Y, Kurklu A, Aydin L, Eren N, Unsal A.
- Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract. 2006 Feb;71(2):210-9 Sengul A.M, Altuntas Y, Kurklu A, Aydin L.
- Improving Metabolic Control with Lispro Therapy in Type 1 Diabetes: The Importance of Basal Insulin. Diabet Bilimi 2004;1:15-18 Şengül A.M, Sargın M, Kürklü A, Sargın H, Canberk E, Uçak S, Ersoy Ç.Y, Argon D, Altuntaş Y.
- Effects of Statins on Microalbuminuria in Patients with Type 2 Diabetes Mellitus Diabet Bilimi 2004;4:186-191. Aydın L, Kürklü A, Uçak S, Şengül A.M, Ersoy Ç.Y, Altuntaş Y.
- Comparison of the effects of carvedilol and metoprolol treatments on insulin resistance and serum lipids in patients after myocardial infarction. Şeh Medical Bulletin 38:1-2004 Basat O, Uçak S, Öztekin E, Şeber S, Kürklü A, Argon D, Altuntaş Y.
- Comparison of PAI-1 and Fibrinogen Levels in Patients with Acute Myocardial Infarction. Şeh Medical Bulletin 45:3-2004 Kürklü A, Aydın L, Şengül A.M, Uçak S, Altuntaş Y.
- Rosiglitazone therapy added to oral antidiabetic combinations or insulin therapy provides metabolic control in type 2 diabetics. Şeh Medical Bulletin 38:1-2004 Uçak S, Basat O, Şeber S, Kürklü A, Ersoy Ç.Y, Altuntaş Y.
- Acarbose Treatment Added to Other Group Oral Antidiabetics Provides Metabolic Control in the First 6 Weeks. Şeh Medical Bulletin 37:3-2003 Uçak S, Basat O, Seber S, Ersoy Ö, Şengül A.M, Kürklü A, Baştürk T, Altuntaş Y.
